Potent thrombin inhibitor 2 is prepared in 10 steps with 20% overall y
ield from commercial 4 on a kg-scale by the convergent approach depict
ed in Schemes 1 and 2. The (R)-configuration of the 4-amidinophenylala
nine piperidide moiety is controlled by asymmetric hydrogenation A nov
el method, the hydrogenolysis of amidoximes 11 and 21, is employed to
attain a particularly clean transformation of the cyano into the amidi
nium functionality. Despite of the amorphous nature of target compound
2, the approach is devoid of any chromatographic purification.